Issue link: http://catalog.e-digitaleditions.com/i/275026
24 EXECUTIVE COMPENSATION Summary Compensation Table The following table summarizes all compensation awarded to, earned by or paid to each of the Company's NEOs during each of the last three fiscal years or such shorter period since he became an NEO. The additional tables that follow the Summary Compensation Table are intended to be supporting presentations to the Summary Compensation Table. Most compensation elements in the supporting tables are aggregated and included in the Summary Compensation Table. You should refer to the section entitled "Compensation Discussion and Analysis" beginning on page 9 to help you understand the compensation practices and programs resulting in the compensation elements in these tables. A narrative description of the material factors necessary to understand the information in the Summary Compensation Table is provided following the table. Name and Principal Position Year Salary ($) Bonus ($) Stock Awards ($) Option Awards ($) Non-Equity Incentive Plan Compensation ($) All Other Compensation ($) Total ($) Kevin A. Lobo ...................... 2013 1,025,000 0 3,000,021 2,854,200 1,340,000 217,698 8,436,919 President and Chief 2012 585,417 79,971 5,928,655 1,792,267 465,421 376,423 9,228,154 Executive Officer 2011 288,750 0 479,678 428,417 162,012 950,821 2,309,678 William R. Jellison ............... 2013 363,920 67,500 985,685 974,056 248,246 173,951 2,813,358 Vice President and Chief Financial Officer(1) Ramesh Subrahmanian ......... 2013 512,500 0 749,941 713,588 345,171 874,850 3,196,050 Group President, 2012 500,000 0 1,110,301 374,159 246,090 551,534 2,782,084 International(2) Timothy J. Scannell .............. 2013 553,333 0 999,964 951,400 399,895 99,887 3,004,479 Group President, 2012 507,222 0 1,255,342 482,657 354,734 87,429 2,687,384 MedSurg and 2011 460,000 0 687,625 594,346 270,123 98,437 2,110,531 Neurotechnology David K. Floyd ..................... 2013 477,500 0 749,941 713,588 415,954 471,032 2,828,015 Group President, Orthopaedics Dean H. Bergy ...................... 2013 349,750 205,219 120,240 122,027 73,799 78,280 949,315 Vice President, 2012 320,667 97,031 120,048 97,041 59,636 38,073 732,496 Corporate Secretary and Former Interim Chief Financial Officer(3) ______________ (1) Mr. Jellison joined the Company on April 22, 2013. (2) USD amounts in this proxy statement with respect to Mr. Subrahmanian have been calculated using calendar quarter 2013 average exchange rates. (3) Mr. Bergy served as Interim Chief Financial Officer in addition to his duties as Vice President, Corporate Secretary until April 22, 2013. Salary. The Salary column represents the base salary paid to the NEO during the reported year. This column includes the portion of salary payments deferred into our 401(k) Plan and Supplemental Plan. Bonus. The Bonus column reflects discretionary cash payments. The discretionary payment to Mr. Jellison in 2013 was a sign- on bonus in connection with his employment with the Company. The discretionary payments to Mr. Bergy in 2012 and 2013 relate to his services as Interim Chief Financial Officer. The discretionary payment to Mr. Lobo in 2012 reflects his performance and the Company's performance after his promotion to President and Chief Executive Officer in October 2012. Payments under our individual NEO bonus plans pursuant to our Executive Bonus Plan are reflected in the Non-Equity Incentive Plan Compensation column and are discussed below under that heading. Stock Awards. The Stock Awards column represents the aggregate grant-date fair value of restricted stock units and performance stock units, calculated in accordance with the Compensation — Stock Compensation Topic of the FASB Codification based on the number of shares granted (target shares for performance stock units) and the closing price of our Common Stock on the last market trading day before the grant date. The grant-date fair value of the NEOs' 2013 performance stock unit awards, if earned at maximum levels, was $6,000,041, $1,499,882, $1,999,928, and $1,499,882 for Mr. Lobo, Mr. Subrahmanian, Mr. Scannell and Mr. Floyd, respectively. Option Awards. The Option Awards column represents the aggregate grant-date fair value of stock option awards calculated in accordance with the Compensation — Stock Compensation Topic of the FASB Codification. Stock option values are derived using the